Channel8 English · 22 Nov 2026
One-Time CRISPR Therapy Cuts "Bad" Cholesterol by 52% in Year-Long Human Trial
A one-time infusion of an experimental CRISPR-Cas9 therapy cut dangerous cholesterol by more than half in a Phase 1 human trial, and the benefit lasted a full year, the Cleveland Clinic reported.
⬅ Back home
Read full article ➡